Latest Press Releases

CG Oncology Announces Pricing of Upsized Initial Public Offering

IRVINE, Calif.--(BUSINESS WIRE)--CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer, today announced...

Upcoming Conferences

We’ll be attending ASCO-GU in San Francisco in January 2024,
and we look forward to connecting with you at the event. 


Media Contact

Bing Kung
Vice President, Business Development
CG Oncology
Kimberly Ha
KKH Advisors
(917) 291-5744